2024-05-10 11:16 | CC:CMND | Clearmind Medicine Inc (3) | 1.60 | News Release200 | Clearmind makes alcohol substitute program progress |
2024-04-30 16:29 | CC:CMND | Clearmind Medicine Inc (3) | 1.60 | News Release200 | Clearmind aims to cease being Cdn reporting issuer |
2024-03-13 20:38 | CC:CMND | Clearmind Medicine Inc (3) | 1.83 | Shares Delisted from CNQ217 | Clearmind Medicine to be delisted from CSE |
2024-03-13 10:46 | CC:CMND | Clearmind Medicine Inc (3) | 2.02 | News Release200 | Clearmind receives approval for voluntary CSE delisting |
2024-02-27 11:45 | CC:CMND | Clearmind Medicine Inc (3) | 2.41 | News Release200 | Clearmind Medicine submits 3 patent applications |
2024-02-23 10:40 | CC:CMND | Clearmind Medicine Inc (3) | 2.47 | News Release200 | Clearmind receives OK for phase 1/2a CMND-100 trial |
2024-02-20 11:08 | CC:CMND | Clearmind Medicine Inc (3) | 2.06 | News Release200 | Clearmind submits three PCT patent applications |
2024-02-05 11:09 | CC:CMND | Clearmind Medicine Inc (3) | 2.39 | News Release200 | Clearmind receives MEAI Chinese patent approval |
2024-02-01 12:18 | CC:CMND | Clearmind Medicine Inc (3) | 2.05 | News Release200 | Clearmind signs licensing agreement with BIRAD |
2024-01-16 16:34 | CC:CMND | Clearmind Medicine Inc (3) | 1.70 | News Release200 | Clearmind Medicine closes offerings for $2.4M (U.S.) |
2024-01-11 12:36 | CC:CMND | Clearmind Medicine Inc (3) | 4.01 | News Release200 | Clearmind prices direct offering, private placement |
2024-01-10 11:03 | CC:CMND | Clearmind Medicine Inc (3) | 2.74 | News Release200 | Clearmind, FDA complete Type A meeting for CMND-100 |
2024-01-04 10:22 | CC:CMND | Clearmind Medicine Inc (3) | 3.48 | News Release200 | Clearmind Medicine reviews 2023 SciSparc partnership |
2023-12-14 12:43 | CC:CMND | Clearmind Medicine Inc (3) | 3.77 | News Release200 | Clearmind Medicine regains compliance with Nasdaq |
2023-12-05 13:07 | CC:CMND | Clearmind Medicine Inc (3) | 5.17 | News Release200 | Clearmind talks cocaine addiction treatment results |
2023-12-01 10:49 | CC:CMND | Clearmind Medicine Inc (3) | 5.00 | News Release200 | Clearmind releases MEAI, PEA preclinical trial results |
2023-11-28 11:20 | CC:CMND | Clearmind Medicine Inc (3) | 4.45 | News Release200 | Clearmind jumps on the weight loss bandwagon |
2023-11-23 17:00 | CC:CMND | Clearmind Medicine Inc (2) | 0.145 | Rollback291 | Clearmind Medicine 1:30 rollback |
2023-11-21 13:33 | CC:CMND | Clearmind Medicine Inc (2) | 0.15 | News Release200 | Clearmind Medicine to roll back shares 1:30 |
2023-11-17 16:20 | CC:CMND | Clearmind Medicine Inc (2) | 0.17 | News Release200 | Clearmind receives delisting notice from Nasdaq |
2023-11-15 13:10 | CC:CMND | Clearmind Medicine Inc (2) | 0.17 | News Release200 | Clearmind shareholders approve all matters at meeting |
2023-11-09 12:08 | CC:CMND | Clearmind Medicine Inc (2) | 0.195 | News Release200 | Clearmind signs CMND-100 trial deal with Johns Hopkins |
2023-09-18 13:24 | CC:CMND | Clearmind Medicine Inc (2) | 0.25 | News Release200 | Clearmind Medicine closes $2.25M (U.S.) public offering |
2023-09-14 11:46 | CC:CMND | Clearmind Medicine Inc (2) | 0.58 | News Release200 | Clearmind prices $2.25M (U.S.) public offering |
2023-09-13 09:45 | CC:CMND | Clearmind Medicine Inc (2) | 0.59 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-09-13 09:43 | CC:CMND | Clearmind Medicine Inc (2) | 0.59 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-09-06 11:55 | CC:CMND | Clearmind Medicine Inc (2) | 0.60 | News Release200 | Clearmind enters clinical trial deal with Johns Hopkins |
2023-08-14 15:59 | CC:CMND | Clearmind Medicine Inc (2) | 0.53 | News Release200 | Clearmind partners with CTS for product development |
2023-08-01 16:14 | CC:CMND | Clearmind Medicine Inc (2) | 0.60 | News Release200 | Clearmind files patent for dyskinesia treatment |
2023-07-17 16:29 | CC:CMND | Clearmind Medicine Inc (2) | 0.58 | News Release200 | Clearmind Medicine issues 17,899 shares to consultants |
2023-07-11 13:29 | CC:CMND | Clearmind Medicine Inc (2) | 0.59 | News Release200 | Clearmind appoints Stanford as scientific adviser |
2023-06-16 10:02 | CC:CMND | Clearmind Medicine Inc (2) | 0.70 | News Release200 | Clearmind, SciSparc to conduct obesity treatment study |
2023-06-14 17:03 | CC:CMND | Clearmind Medicine Inc (2) | 0.68 | SEDAR MD & A815 | SEDAR MD & A |
2023-06-14 17:02 | CC:CMND | Clearmind Medicine Inc (2) | 0.68 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-06-09 10:48 | CC:CMND | Clearmind Medicine Inc (2) | 0.71 | News Release200 | Clearmind to hold virtual investor conference June 12 |
2023-05-23 12:14 | CC:CMND | Clearmind Medicine Inc (2) | 0.83 | News Release200 | Clearmind selects first U.S. site for CMND-100 trial |
2023-05-19 16:22 | CC:CMND | Clearmind Medicine Inc (2) | | News Release200 | Clearmind fails to meet Nasdaq minimum bid price |